LUCAS SVETLANA enters SCRIBE THERAPEUTICS, INC. with 30.70K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives

LUCAS SVETLANA

Filed: 7/24/2026ACC: 0001781292-26-000005

InsiderLUCAS SVETLANACIK 1781292

→

IssuerSCRIBE THERAPEUTICS, INC.CIK 1853921

Officer· Chief Business Officer

Since Jul 2026

30.70K

Baseline shares

100% direct

30.70K

Direct ownership

1 position

91.33K

Derivative underlying

5 instruments

Security positions

All direct

Non-Derivative Holdings1

Common Stock

Direct

Shares owned30.70K

Total

30.70K direct30.70K

Security Title	Shares Owned	Ownership Type
Common Stock	30.70K	Direct
Total	30.70K	30.70K direct

Derivative Holdings5

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

21.11K

Shares owned

N/A

Exercise price

6.40

Expiration

—

Exercise window

—

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

13.02K

Shares owned

N/A

Exercise price

3.08

Expiration

—

Exercise window

—

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

9.55K

Shares owned

N/A

Exercise price

19.13

Expiration

—

Exercise window

—

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

34.49K

Shares owned

N/A

Exercise price

2.85

Expiration

—

Exercise window

—

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

13.17K

Shares owned

N/A

Exercise price

6.40

Expiration

—

Exercise window

—

Total

Underlying

91.33K

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Stock Option (Right to Buy) Direct	Common Stock	6.40	—	—	21.11K	N/A
Stock Option (Right to Buy) Direct	Common Stock	3.08	—	—	13.02K	N/A
Stock Option (Right to Buy) Direct	Common Stock	19.13	—	—	9.55K	N/A
Stock Option (Right to Buy) Direct	Common Stock	2.85	—	—	34.49K	N/A
Stock Option (Right to Buy) Direct	Common Stock	6.40	—	—	13.17K	N/A
Total					91.33K	0.00